In contrast however, patients with CRC exhibiting mutated BRAF, CIMP-positive, and MSI-high were significantly less likely to die from their disease than those with traditional adenoma–carcinoma pathway tumors [105]; thus, even among patients with CRC suggestive of serrated pathway origins, there is considerable heterogeneity in clinical outlook. Here, BRAF is linked to colorectal carcinoma.